...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke
【24h】

Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke

机译:泰国急性缺血性卒中患者静脉溶栓后脑出血

获取原文
获取原文并翻译 | 示例
           

摘要

In Asia, there is limited information regarding symptomatic intracerebral hemorrhage (ICH) in patients treated with intravenous (iv) recombinant tissue plasminogen activator (rtPA). The aim of this study was to identify independent factors associated with symptomatic ICH following iv rtPA. The study included 192 patients with acute ischemic stroke who were treated with iv rtPA. Baseline characteristics were compared between patients with or without ICH. Symptomatic ICH occurred in 5.7% of patients and asymptomatic ICH in 13.0% of patients. An international normalized ratio (INR) ≥1.0 (odds ratio [OR] = 4.89, p = 0.036), atrial fibrillation (OR = 7.21, p = 0.009) and blood glucose concentration >8.325 mmol/L (OR = 9.00, p = 0.004), were independent risk factors for symptomatic ICH. Atrial fibrillation (OR = 3.56, p = 0.012) and severe stroke (National Institutes of Health Stroke Scale ≥15; OR = 8.94, p < 0.001) were independent risk factors for asymptomatic ICH. The prevalence of symptomatic ICH following iv rtPA in Thai patients was comparable to previous studies.
机译:在亚洲,有关接受静脉内(iv)重组组织纤溶酶原激活剂(rtPA)治疗的患者的症状性脑出血(ICH)的信息很少。这项研究的目的是确定iv rtPA后与症状性ICH相关的独立因素。该研究纳入了192例接受静脉rtPA治疗的急性缺血性中风患者。比较有或没有ICH的患者的基线特征。有症状的ICH发生在5.7%的患者中,而无症状的ICH发生在13.0%的患者中。国际标准化比(INR)≥1.0(比值[OR] = 4.89,p = 0.036),房颤(OR = 7.21,p = 0.009)和血糖浓度> 8.325 mmol / L(OR = 9.00,p = 0.004)是症状性ICH的独立危险因素。心房颤动(OR = 3.56,p = 0.012)和重度中风(美国国立卫生研究院卒中量表≥15; OR = 8.94,p <0.001)是无症状ICH的独立危险因素。 rtrtPA后泰国患者中症状性ICH的患病率与以前的研究相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号